Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Last updated: 2021
Remove filter for
Type: Health professional risk communication
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 15 of 25 items.
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation for Use in Children Aged 5 Years to Less Than 12 Years
IMPORTANT: Access to Canadian-specific labelling information during the distribution of COMIRNATY (COVID-19 Vaccine, mRNA also referred to as Pfizer-BioNTech COVID-19 Vaccine) for Children Aged 5 Years to Less Than 12 Years.
Audience…
AlertHealth professional risk communication | 2021-11-19
Distribution of SPIKEVAX (elasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels
IMPORTANT: Access to Canadian-specific labelling information during the distribution of the SPIKEVAX (elasomeran) COVID-19 Vaccine with English-only vial and carton labels.
Audience
Healthcare professionals including infectious disease physicians,…
AlertHealth professional risk communication | 2021-11-10
Importation of Janssen COVID-19 Vaccine with European Union (EU) English-only Vial and Carton Labels
IMPORTANT: Access to storage and expiry date instructions during the distribution of the Janssen COVID-19 Vaccine with EU English-only labels.
Audience
Healthcare professionals including infectious disease physicians, pharmacists, family…
AlertHealth professional risk communication | 2021-11-05
Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic
Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic
Starting date:
September 22, 2021…
AlertHealth professional risk communication | 2021-10-04
Important Safety Information on Ultrasound Gels and Lotions Manufactured by Eco-Med Pharmaceuticals, Inc. - Potential Contamination with Burkholderia stabilis
Important Safety Information on Ultrasound Gels and Lotions Manufactured by Eco-Med Pharmaceuticals, Inc. - Potential Contamination with Burkholderia stabilis…
AlertHealth professional risk communication | 2021-08-19
Recall of EcoGel 200 Ultrasound Gel - MediChoice (M500812) – Contamination with Burkholderia stabilis
Recall of EcoGel 200 Ultrasound Gel - MediChoice (M500812) – Contamination with Burkholderia stabilis
Starting date:…
AlertHealth professional risk communication | 2021-08-13
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
Starting…
AlertHealth professional risk communication | 2021-07-30
CHAMPIX (varenicline) — Potential Risk Posed by Long-Term Exposure to Nitrosamine Impurity, N-nitrosovarenicline, Exceeding Acceptable Intake Limit
CHAMPIX (varenicline) — Potential Risk Posed by Long-Term Exposure to Nitrosamine Impurity, N-nitrosovarenicline, Exceeding Acceptable Intake Limit…
AlertHealth professional risk communication | 2021-06-30
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
Starting date:
June 29, 2021…
AlertHealth professional risk communication | 2021-06-29
Medtronic Heartware Ventricular Assist Device System - Recall Due to Risk of Neurological Adverse Events, Mortality and Delay or Failure to Restart
Medtronic Heartware Ventricular Assist Device System - Recall Due to Risk of Neurological Adverse Events, Mortality and Delay or Failure to Restart…
AlertHealth professional risk communication | 2021-06-25
Importation of COVID-19 Vaccine Moderna with up to 15 Doses per Vial and English-only Vial and Carton Labels (US-Labelled Supply)
UPDATED INFORMATION – October 29, 2021
Further to the Health Canada communications below issued on June 14, 2021 (and updated on June 24, 2021, and August 3, 2021), Health Canada has authorized a 2-month shelf life extension (from 7 months to 9 months…
AlertHealth professional risk communication | 2021-06-14
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
Starting date:…
AlertHealth professional risk communication | 2021-04-28
Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels
Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels
Starting date:
April 26,…
AlertHealth professional risk communication | 2021-04-26
Janssen COVID-19 Vaccine and the Risk of Thrombosis with Thrombocytopenia
Janssen COVID-19 Vaccine and the Risk of Thrombosis with Thrombocytopenia
Starting date:
April 26, 2021…
AlertHealth professional risk communication | 2021-04-26
Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels (US-Labelled Supply)
Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels (US-Labelled Supply)
Starting date:…
AlertHealth professional risk communication | 2021-03-31